Vanda Pharmaceuticals buy StockNews.com
Start price
29.07.23
/
50%
€5.25
Target price
29.07.24
-
Performance (%)
-3.81%
Price
17.05.24
€5.05
Summary
This prediction is currently active. With a performance of -3.81%, the BUY prediction by StockNews_com is trending in the wrong direction. This prediction currently runs until 29.07.24. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Vanda Pharmaceuticals | 7.906% | 7.906% |
iShares Core DAX® | 0.051% | 5.593% |
iShares Nasdaq 100 | 1.808% | 7.445% |
iShares Nikkei 225® | 2.181% | 2.815% |
iShares S&P 500 | 1.040% | 4.975% |
Comments by StockNews_com for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for VNDA provided by MarketBeat